Home > Insider Trading > Filing (0001144204-14-052149)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1279704	Cellectar Biosciences Inc.	CLRB	Pharmaceutical Preparations (2834)	043321804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1167426	John Neis	C/O Cellectar Biosciences, Inc. 3301 Agriculture Drive Madison WI 53719		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.00001 Per Share	Acquisiton	2014-08-20	130,000	$3.75	493,715	No	4	P	Indirect	See Foonote
Common Stock, Par Value $0.00001 Per Share	Acquisiton	2014-08-20	138,711	$3.75	632,426	No	4	P	Indirect	See Foonote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Foonote
No	4	P	Indirect	See Foonote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Purchase Warrant (right to buy)	Acquisiton	2014-08-20	130,000	$0.01	130,000	$4.68
Common Stock	Convertible Debenture (right to buy)	Disposition	2014-08-20	50,000	$3.75	50,000	$10.00
Common Stock	Stock Purchase Warrant (right to buy)	Acquisiton	2014-08-20	138,711	$0.01	138,711	$4.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
130,000	2014-08-20	2019-08-20	No	4	P	Indirect
0	2014-02-06	2016-02-06	No	4	S	Indirect
268,711	2014-08-20	2019-08-20	No	4	P	Indirect

Footnotes

These securities are held by Venture Investors Early Stage Fund IV Limited Partnership and Advantage Capital Wisconsin Partners I, Limited Partnership. VIESF IV GP LLC is the general partner of Venture Investors Early Stage Fund IV Limited Partnership and Venture Investors LLC is the submanager and special limited partner of Advantage Capital Wisconsin Partners I, Limited Partnership. The investment decisions of VIESF IV GP LLC and Venture Investors LLC are made collectively by seven managers, including the reporting person. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
These securities were issued in consideration of the tender to the issuer by Venture Investors Early Stage Fund IV Limited Partnership and Advantage Capital Wisconsin Partners I, Limited Partnership of convertible debentures with an aggregate principal amount and accrued interest equal to the purchase price of the securities.
These securities were tendered to the issuer by Venture Investors Early Stage Fund IV Limited Partnership and Advantage Capital Wisconsin Partners I, Limited Partnership in consideration of the purchase of shares of Common Stock and Stock Purchase awards as described elsewhere in this Form 4.